Meridian Bioscience to Hold First Quarter 2022 Financial Results Conference Call on February 4, 2022
CINCINNATI, Jan. 10, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, will report first quarter 2022 financial results Friday, February 4, 2022. Jack Kenny, Chief Executive Officer, will host a conference call beginning at 10:00 a.m. Eastern Time to discuss the results and answer questions. To participate in the live call by webcast, join directly here or visit investor.meridianbioscience.com for the link. If you are unable to join the webcast, you may join by telephone. From the U.S., dial (877) 407-0890, or from outside the U.S., dial (201) 389-0918, and provide the code 13726037. A replay of the conference call will also be available by webcast for one year beginning 1:00 p.m. Eastern Time on February 4, 2022 using the link provided at investor.meridianbiocience.com. About Meridian Bioscience, Inc. Meridian's shares are traded on the NASDAQ Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com. Contact: View original content to download multimedia:https://www.prnewswire.com/news-releases/meridian-bioscience-to-hold-first-quarter-2022-financial-results-conference-call-on-february-4-2022-301457240.html SOURCE Meridian Bioscience, Inc. |
||
Company Codes: NASDAQ-NMS:VIVO |